Yungjin Pharm. Co., Ltd.
KSE 003520.KS
Yungjin Pharm. Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 182,892,454
Yungjin Pharm. Co., Ltd. Shares (Diluted, Weighted) is 182,892,454 for the year ending December 31, 2023, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
-
Yungjin Pharm. Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 182,892,454, a 0.00% change year over year.
-
Yungjin Pharm. Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 182,892,454, a 0.00% change year over year.
-
Yungjin Pharm. Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 182,892,454, a 0.00% change year over year.
-
Yungjin Pharm. Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 182,892,454, a -1.07% change year over year.
Key data
| Date | Shares (Diluted, Weighted) | Revenue | Cost of Revenue | Gross Profit |
|---|
Market news
Loading...
KSE: 003520.KS
| CEO | Mr. Chae-Joon Lee |
| IPO Date | Jan. 8, 2001 |
| Location | South Korea |
| Headquarters | 13, Olympic-ro 35da-gil |
| Employees | 574 |
| Sector | Health Care |
| Industries | |
Description
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.
Key trends
Past 5 years
Similar companies
Yuhan Corporation
USD 89.21
-4.31%
Bukwang Pharmaceutical Co., Ltd.
USD 3.32
0.12%
Green Cross Corporation
USD 108.37
-2.33%
Boryung Corporation
USD 7.02
1.13%
Daewoong pharmaceutical Co.,Ltd
USD 89.82
-0.84%
StockViz Staff
January 15, 2025
Any question? Send us an email